Can Myriad Genetics, Inc. (MYGN) Survive the Supreme Court?

The market has been less than thrilled about an upcoming Supreme Court decision on the legality of the best-selling analytical test of Myriad Genetics, Inc. (NASDAQ:MYGN) .

Keep Reading →

March 5th, 2013 - News